文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

术前地塞米松对疑似阑尾炎腹腔镜术后恶心呕吐影响的随机临床试验

Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis.
PubMed 文献 · Br J Surg · 2017-01-10

这项多中心、双盲、安慰剂对照试验在丹麦两家大学医院纳入120例因疑似急性阑尾炎行腹腔镜手术的成人,术前30分钟静脉给予8 mg地塞米松。但地塞米松组静息疼痛、疲劳、阿片类药物用量及恢复质量均优于安慰剂组。

核心结论

  • 术前8 mg地塞米松未将术后第一天恶心呕吐发生率降低至预设的50%目标水平。
  • 地塞米松组在静息疼痛、疲劳、阿片类药物用量及恢复质量方面优于安慰剂组。

研究设计与样本

  • 多中心、平行组、双盲、安慰剂对照随机临床试验,在丹麦两家大学医院开展。
  • 纳入因疑似急性阑尾炎行腹腔镜手术的成人,共120例入组,地塞米松组57例、安慰剂组59例纳入主要分析。
  • 干预为术前30分钟静脉给予8 mg地塞米松,主要结局为术后第一天恶心呕吐发生率,按意向性治疗原则分析。

主要发现

  • 地塞米松组术后第一天恶心呕吐发生率为47%(95%CI 35%-60%),安慰剂组为63%(95%CI 50%-74%)。

临床怎么用

  • 对于疑似阑尾炎行腹腔镜手术的成人,术前8 mg地塞米松虽未显著降低恶心呕吐,但可减轻静息疼痛和疲劳、减少阿片类药物用量并改善恢复质量。
  • 临床决策时可结合患者个体情况考虑术前使用地塞米松以改善术后恢复质量,但不应期望其单独达到50%的恶心呕吐降幅目标。

局限性

  • 研究仅纳入丹麦两家大学医院的患者,外推性可能受限。
  • 主要结局未达到统计学显著性,绝对风险降低的95%CI跨零。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have investigated the effects of preoperative dexamethasone in acute surgical patients. This study examined the effects of 8 mg dexamethasone administered intravenously 30 min before surgery for suspected acute appendicitis. METHODS: A multicentre, parallel-group, double-blind, placebo-controlled study was conducted at two university hospitals in Denmark. Adults undergoing laparoscopic surgery for suspected appendicitis were eligible for inclusion. Participants, healthcare staff and investigators were blinded until all data analysis had been done. The primary outcome was the incidence of postoperative nausea and vomiting (PONV) during the first postoperative day. Secondary outcomes were pain, fatigue, sleep, opioid consumption, use of antiemetics, quality of recovery and duration of convalescence. Analysis was done according to the intention-to-treat principle. RESULTS: A total of 120 patients were enrolled; 57 patients in the dexamethasone group and 59 in the placebo group were eligible for primary analysis. In the dexamethasone group, 47 (95 per cent c.i. 35 to 60) per cent of patients experienced PONV compared with 63 (50 to 74) per cent) in the placebo group. The absolute risk reduction in PONV was 15 (-3 to 33) per cent in favour of the dexamethasone group (P = 0·098). Patients in the dexamethasone group had less pain at rest (difference in score on visual analogue scale (VAS) 9 (95 per cent c.i. 1 to 17) mm; P = 0·024), were less fatigued (difference in VAS score 7 (0 to 14) mm; P = 0·038), used fewer opioids (absolute risk reduction 17 (2 to 33) per cent; P = 0·033) and had better quality of recovery (difference in QoR-15 score 13 (4 to 22); P = 0·006) during the first postoperative day. There was no difference in postoperative complications (P = 0·595). CONCLUSION: Preoperative dexamethasone did not reduce PONV by the target level of 50 per cent. Registration number: NCT02415335 ( http://www.clinicaltrials.gov).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Kleif J, Kirkegaard A, Vilandt J, et al. Randomized clinical trial of preoperative dexamethasone on postoperative nausea and vomiting after laparoscopy for suspected appendicitis. Br J Surg. 2017. PMID: 28072446. doi:10.1002/bjs.10418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。